2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione | |
---|---|
Trade Name | |
Orphan Indication | Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes |
EU Market Approval | EU |
EU Designation Date | 2017-12-12 00:00:00 |
Sponsor | NeuroVive Pharmaceutical AB |